Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John L. Flavin currently holds 413,015 shares of Pyxis Oncology, Inc. (PYXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John L. Flavin has been a net buyer of PYXS stock. They have purchased $1.1K and sold $0 worth of shares.
John L. Flavin's most recent insider trade was on Mar 26, 2024, when they sold 35,219 shares at $0.00 per share.
John L. Flavin serves as Executive at Pyxis Oncology, Inc. (PYXS). They have executed 5 insider transactions totaling $1.1K over their tenure at the company.
John L. Flavin holds the position of Executive at Pyxis Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
John L. Flavin has shown a buying trading pattern, with $1.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John L. Flavin was on Feb 27, 2008, when they purchased $1.1K worth of ADLS shares. This transaction involved 1,200 shares at $0.91 per share.
John L. Flavin currently owns 413,015 shares of Pyxis Oncology, Inc. (PYXS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John L. Flavin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John L. Flavin has 5 Form 4 filings on record as an insider at Pyxis Oncology, Inc..
Set alerts for John L. Flavin and 40,000+ other insiders.